Neurocrine Biosciences Inc vs Newegg Commerce Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Newegg Commerce Inc trades at $13.12 (market cap $270.98M). The key difference: Neurocrine Biosciences Inc is far larger — about 64.2× Newegg Commerce Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | NEGG | |
|---|---|---|
Market Cap | $17.40B | $270.98M |
Sector | Health | Consumer Cyclical |
52-Week High | $180.55 | $128.09 |
52-Week Low | $123.10 | $12.92 |
Enterprise Value | $16.49B | $269.78M |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →